A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

New England Journal of Medicine

Volumn 338, Issue 21, 1998, Pages 1498-1505

  White, Harvey ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; TIROFIBAN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ASPIRIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROPORTIONAL HAZARDS MODELS; TYROSINE;

EID: 2642654221     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199805213382103     Document Type: Article

References (28)

1. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985;53:363-73.
2. Théroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988;319:1105-11.
3. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous herapin in men with unstable coronary artery disease. Lancet 1990;336:827-30.
4. Cohen M, Adams PC, Parry G, et al. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users: primary end points analysis from the ATACS trials: Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Circulation 1994;89:81-8.
5. Gurfinkel EP, Manos EJ, Mejail RI, et al. Low molecular weight herapin versus regular herapin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol 1995;26:313-8.
6. Holdright D, Patel D, Cunningham D, et al. Comparison of the effect of herapin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina. J Am Coll Cardiol 1994;24:39-45.
7. Théroux P, Waters D, Lam J, Juneau M, McCans J. Reactivation of unstable angina after the discontinuation of herapin. N Engl J Med 1992; 327:141-5.
8. Lewis HD Jr, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration cooperative study. N Engl J Med 1983;309:396-403.
9. Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian multicenter trial. N Engl J Med 1985;313:1369-75.
10. Balsano F, Rizzon P, Violi F, et al. Antiplatelet treatment with ticlopidine in unstalbe angina: a controlled multicenter clinical trial: the Studio della Ticlopidina nell'Angina Instabile Group. Circulation 1990;82:17-26.
11. Lynch JJ Jr, Cook JJ, Sitko GR, et al. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383. J Pharmacol Exp Ther 1995;272:20-32.
12. Theroux P, White H, David D, et al. A heparin-controlled study of MK-383 in unstable angina. Circulation 1994;90:Suppl:I-231. abstract.
13. Bovill EG, Terrin ML, Stump DC, et al. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. Ann Intern Med 1991;115:256-65.
14. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
15. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-96.
16. The RESTORE Investigators. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 1997;96:1445-53.
17. Tcheng JE, Harrington RA, Kottke-Marchant K, et al. Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. Circulation 1995;91:2151-7.
18. The CAPTURE Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refratory unstable angina: the CAPTURE Study. Lancet 1997;349:1429-35.
19. Vermeer F, Werter C, Col J, et al. Improved coronary anatomy after thrombolysis in patients with unstable angina: the UNASEM Study: results of quantitative coronary angiography. Circulation 1991;84:Suppl II: II-252. abstract.
20. Rizik D, Healy S, Margulis A, et al. Prediction of in-hospital outcome in unstable angina: a novel clinical classification. Circulation 1991;84:Suppl II:II-347. abstract.
21. Bär FW, Verheugt FW, Col J, et al. Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome: results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase. Circulation 1992;86:131-7.
22. Lee HS, Cross SJ, Rawles JM, Jennings KP. Patients with suspected myocardial infarction who present with ST depression. Lancet 1993;342: 1204-7.
23. Bazzino O, Paviotti CE, Tajer CD, et al. ECLA 3: clinical predictors of in-hospital prognosis in unstable angina. Circulation 1993;88:Suppl: I-608. abstract.
24. Bittl JA, Strony J, Brinker JA, et al. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. N Engl J Med 1995;333:764-9.
25. Armstrong PW, Califf RM, Granger CB, Woodlief LH, Topol EJ. Recurrent ischemia in the GUSTO IIb trial. Circulation 1996;94:Suppl I: I-381-I382. abstract.
26. The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338:1488-97.
27. Granger CB, Miller JM, Bivill EG, et al. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 1995;91:1929-35.
28. Granger CB, Hirsch J, Califf RM, et al. Activated partial thromboplastin time and outcome after thrombplytic therapy for acute myocardial infarction: results from the GUSTO-I trial. Circulation 1996;93:870-8.